Delivery Order SPE2DB24D8001-SPE2DB24FKYVX

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZQD, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is a delivery order with a firm fixed price of $3,749.42 and an ultimate completion date of April 30, 2025. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program and allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYZJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Dakota Drug, Inc. The contract is a delivery order valued at $6,456.93, with a firm fixed-price pricing structure. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which...
This federal contract award, identified as SPE2DB24D8003 and SPE2DB25FJUJM, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is a delivery order valued at $3,220.56 and has a firm fixed-price pricing type. The contract is not set-aside and has an ultimate completion date of May 9, 2025. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which seeks to...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYWG, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, which is a Delivery Order under the DLA Troop Support Medical's ECAT Generation V Program, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, including prescription medications, medical devices, vaccines, and other healthcare-related items. The contract...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZHD, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S. Armed Forces medical operations. The contract is an Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, with a ceiling value of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DB24D8001, is part of the DLA Troop Support Medical's ECAT Generation V Program and has a ceiling value of $5,267.34. It is an unrestricted, non-set-aside contract that allows Dakota Drug, Inc. to provide a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S....
The U.S. Defense Logistics Agency (DLA) awarded a $2,468.17 firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of pharmaceutical products, medical supplies, and healthcare equipment. The contract, identified as SPE2DB24D8003|SPE2DB25FJTZF, has an ultimate completion date of March 14, 2025. This award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZDT, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,528.94 and is a Firm Fixed Price Delivery Order. It is not associated with a set-aside program. Dakota...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The award, valued at $3,457.84, is a delivery order under the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support Medical's ECAT Generation V Program. This...
This federal contract award, identified as SPE2DX15D8001|SPE2DX23FBQCN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $7,745.85 firm fixed-price delivery order is for the provision of various pharmaceutical products and medical supplies, including insulin pens, inhalers, anticoagulants, and biologic drugs, to support U.S. Armed Forces medical...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB24FKYVX
    Delivery Order

This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYVX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The contract is a firm-fixed-price delivery order valued at $7,483.78, with an ultimate completion date of August 2, 2024.

Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The company specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, primarily the Department of Defense. This contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which seeks to procure commercial medical equipment, accessories, consumables, and medical simulation equipment from manufacturers and distributors. The contract does not have a set-aside designation.

Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00 and extending through December 31, 2025. This IDC positions the company as a key supplier for the DLA's military medical supply programs, enabling the agency to efficiently procure essential medical items for various defense healthcare facilities and operations.

Generated 10/31/24, 10:14 AM